The Lupus Foundation of America (LFA) celebrated exceptional lupus researchers at the 20th Anniversary Evelyn V. Hess ...

The new guidelines include three strong recommendations: Universal treatment with hydroxychloroquine (absent ...

The Lupus Foundation of America (LFA) and its funded researchers will unveil the latest advances in patient-centered research ...

The U.S. Food and Drug Administration (FDA) has approved Gazyva® (obinutuzumab), developed by Genentech, as a treatment for adults with lupus nephritis (LN), also known as lupus-related kidney disease ...

There are multiple chapters near you. Select your preferred chapter.

The Lupus Foundation of America is dedicated to improving the quality of life for all people affected by lupus through programs of research, education, and advocacy.

Medicare Part D provides prescription drug coverage for more than 50 million of America's seniors and those living with chronic diseases like lupus. Part D allows timely, affordable access to ...

In a new study, researchers found people with clinically active systemic lupus erythematosus (SLE) disease on standard of care can attain or achieve low disease activity (LLDAS) and meet the ...

A new study has found that women with systemic lupus erythematosus who have problems with memory and thinking (mild cognitive impairment, or MCI) exhibit morphological brain changes, which may serve ...

Join the cause by staying informed, making a donation, joining an event or becoming an advocate for those with lupus and their families.

Day-to-day life with lupus can be challenging and can take a toll on your mental health. Whether you are newly diagnosed or have been living with lupus for years, it's important to pay attention to ...

Our approach is innovative and removes barriers to progress. Watch this short video about three of our bold research initiatives to better understand lupus in children and teens, improve early ...